HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$1.26
Day range
$1.23 - $1.26
Year range
$1.01 - $13.00
Market cap
90.66M USD
Avg Volume
791.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 37.83M | -42.09% |
Net income | -48.28M | -579.53% |
Net profit margin | — | — |
Earnings per share | -0.67 | -578.57% |
EBITDA | -37.56M | -53.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 332.45M | -32.01% |
Total assets | 384.02M | -31.11% |
Total liabilities | 88.64M | -10.20% |
Total equity | 295.38M | — |
Shares outstanding | 71.95M | — |
Price to book | 0.31 | — |
Return on assets | -23.22% | — |
Return on capital | -26.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -48.28M | -579.53% |
Cash from operations | -32.64M | 37.21% |
Cash from investing | 40.48M | -34.24% |
Cash from financing | 189.00K | 2,600.00% |
Net change in cash | 8.03M | -16.18% |
Free cash flow | -16.07M | 11.05% |
About
Founded
2014
Website
Employees
166
